---
$id: https://graph.org.ai/products/commodity/51281602
$type: Product
source: UNSPSC
code: "51281602"
title: "Spectinomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Spectinomycin

**UNSPSC Code**: 51281602
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93AKI1U6QF, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)- but generally known as spectinomycin, which bears US NIH Compound Identifier 2021. European Medicines Agency schedules Spectinomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG. The term SPECTINOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules spectinomycin in its Anatomical Therapeutic Chemical (ATC) Classification. SPECTINOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spectinomycin under HS 29419000 and SITC 54139. As of Q4 2014, SPECTINOMYCIN remains the US FDA Preferred Term for this commodity. Spectinomycin bears US NLM identifiers UMLS ID C0001268 and NCI Concept Code C61951. SMILES: O1C2C(OC3OC(CC(=O)C13O)C)C(O)C(NC)C(O)C2NC.

